These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 24051573

  • 21. Cocaine-induced psychotic symptoms in French cocaine addicts.
    Vorspan F, Brousse G, Bloch V, Bellais L, Romo L, Guillem E, Coeuru P, Lépine JP.
    Psychiatry Res; 2012 Dec 30; 200(2-3):1074-6. PubMed ID: 22551940
    [Abstract] [Full Text] [Related]

  • 22. DHEAS and POMS measures identify cocaine dependence treatment outcome.
    Wilkins JN, Majewska MD, Van Gorp W, Li SH, Hinken C, Plotkin D, Setoda D.
    Psychoneuroendocrinology; 2005 Jan 30; 30(1):18-28. PubMed ID: 15358439
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Increased serum brain-derived neurotrophic factor levels during opiate withdrawal.
    Zhang J, Zhang X, Su H, Tao J, Xie Y, Han B, Lu Y, Wei Y, Sun H, Wang Y, Wu W, Zou S, Liang H, Zoghbi AW, Tang W, He J.
    Neurosci Lett; 2014 Jun 13; 571():61-5. PubMed ID: 24810885
    [Abstract] [Full Text] [Related]

  • 26. Serum brain-derived neurotrophic factor in patients with trauma psychopathology.
    Hauck S, Kapczinski F, Roesler R, de Moura Silveira E, Magalhães PV, Kruel LR, Schestatsky SS, Ceitlin LH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr 16; 34(3):459-62. PubMed ID: 20097247
    [Abstract] [Full Text] [Related]

  • 27. Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia.
    Rizos EN, Michalopoulou PG, Siafakas N, Stefanis N, Douzenis A, Rontos I, Laskos E, Kastania A, Zoumpourlis V, Lykouras L.
    Neuropsychobiology; 2010 Apr 16; 62(2):87-90. PubMed ID: 20523079
    [Abstract] [Full Text] [Related]

  • 28. Risk factors for experiencing psychosis during cocaine use: a preliminary report.
    Floyd AG, Boutros NN, Struve FA, Wolf E, Oliwa GM.
    J Psychiatr Res; 2006 Mar 16; 40(2):178-82. PubMed ID: 16048728
    [Abstract] [Full Text] [Related]

  • 29. Brain-derived neurotrophic factor levels and depression during methamphetamine withdrawal.
    Ren W, Luan X, Zhang J, Gutteea P, Cai Y, Zhao J, Gu Y, Wu C, Su H, Tao J, Xie Y, Lv D, Feng L, He J.
    J Affect Disord; 2017 Oct 15; 221():165-171. PubMed ID: 28647666
    [Abstract] [Full Text] [Related]

  • 30. A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.
    Alexander PD, Gicas KM, Willi TS, Kim CN, Boyeva V, Procyshyn RM, Smith GN, Thornton AE, Panenka WJ, Jones AA, Vila-Rodriguez F, Lang DJ, William MacEwan G, Honer WG, Barr AM.
    Psychopharmacology (Berl); 2017 May 15; 234(9-10):1535-1547. PubMed ID: 28190084
    [Abstract] [Full Text] [Related]

  • 31. Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review.
    Martinotti G, Di Iorio G, Marini S, Ricci V, De Berardis D, Di Giannantonio M.
    J Biol Regul Homeost Agents; 2012 May 15; 26(3):347-56. PubMed ID: 23034254
    [Abstract] [Full Text] [Related]

  • 32. BDNF and GDNF serum levels in alcohol-dependent patients during withdrawal.
    Heberlein A, Muschler M, Wilhelm J, Frieling H, Lenz B, Gröschl M, Kornhuber J, Bleich S, Hillemacher T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug 16; 34(6):1060-4. PubMed ID: 20553781
    [Abstract] [Full Text] [Related]

  • 33. No change between the serum brain-derived neurotrophic factor in female patients with anorexia nervosa before and after partial weight recovery.
    Nakazato M, Hashimoto K, Yoshimura K, Hashimoto T, Shimizu E, Iyo M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug 30; 30(6):1117-21. PubMed ID: 16753247
    [Abstract] [Full Text] [Related]

  • 34. Higher severity of cocaine addiction is associated with tactile and somatic hallucinations.
    Roncero C, Grau-López L, Palma-Álvarez RF, Rodriguez-Cintas L, Ros-Cucurull E, Esojo A, Daigre C.
    Eur Psychiatry; 2017 May 30; 42():63-69. PubMed ID: 28212507
    [Abstract] [Full Text] [Related]

  • 35. Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia.
    Niitsu T, Shirayama Y, Matsuzawa D, Hasegawa T, Kanahara N, Hashimoto T, Shiraishi T, Shiina A, Fukami G, Fujisaki M, Watanabe H, Nakazato M, Asano M, Kimura S, Hashimoto K, Iyo M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec 01; 35(8):1836-40. PubMed ID: 21930178
    [Abstract] [Full Text] [Related]

  • 36. Cocaine-induced psychotic symptoms in clinical setting.
    Vergara-Moragues E, Araos Gómez P, González-Saiz F, Rodríguez-Fonseca F.
    Psychiatry Res; 2014 Jun 30; 217(1-2):115-20. PubMed ID: 24679995
    [Abstract] [Full Text] [Related]

  • 37. Increased serum brain-derived neurotrophic factor is predictive of cocaine relapse outcomes: a prospective study.
    D'Sa C, Fox HC, Hong AK, Dileone RJ, Sinha R.
    Biol Psychiatry; 2011 Oct 15; 70(8):706-711. PubMed ID: 21741029
    [Abstract] [Full Text] [Related]

  • 38. Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy.
    Kobayashi K, Shimizu E, Hashimoto K, Mitsumori M, Koike K, Okamura N, Koizumi H, Ohgake S, Matsuzawa D, Zhang L, Nakazato M, Iyo M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun 15; 29(5):658-63. PubMed ID: 15905010
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of oxidative stress and brain-derived neurotrophic factor levels related to crack-use detoxification.
    Hirsch GE, Jaskulski M, Hamerski HM, Porto FG, da Silva B, Aita CAM, Kroker K, de Bem Silveira G, Silveira PCL, Santos GT, Klafke JZ, Viecili PRN.
    Neurosci Lett; 2018 Mar 23; 670():62-68. PubMed ID: 29374540
    [Abstract] [Full Text] [Related]

  • 40. Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety.
    Molendijk ML, Bus BA, Spinhoven P, Penninx BW, Prickaerts J, Oude Voshaar RC, Elzinga BM.
    World J Biol Psychiatry; 2012 Oct 23; 13(7):535-43. PubMed ID: 21888560
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.